Equities research analysts expect Seres Therapeutics, Inc. (NASDAQ:MCRB) to post sales of $19.48 million for the current quarter, according to Zacks. Four analysts have issued estimates for Seres Therapeutics’ earnings, with estimates ranging from $5.00 million to $58.30 million. Seres Therapeutics reported sales of $17.56 million in the same quarter last year, which indicates a […]
